RHT
Click for more information
4.92% 6.4¢ resonance health limited

"By 2020 NASH will overtake hepatitis C as the No. 1 cause of...

  1. Nutsy
    2,682 Posts.
    lightbulb Created with Sketch. 340
    clock Created with Sketch.
    03/01/19
    22:07
    Post #: 37018883
    "By 2020 NASH will overtake hepatitis C as the No. 1 cause of liver transplantation in the U.S.," says Dr. Maria Yataco, a gastroenterologist who is conducting research on NASH and liver disease at the Mayo Clinic in Jacksonville.
    RHT Price at posting: 9.4¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TG6 TG Metals reports high grade lithium hits approaching 3% at Jaegermeister
right-arrow Created with Sketch.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
right-arrow Created with Sketch.
QBE QBE records share price plunge despite doubling profits in the first half of 2024
right-arrow Created with Sketch.
NEWS Bitcoin: Current State of Play & Where to Next | Swyftx
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market
right-arrow Created with Sketch.
RLT South Africa-based Renergen brings liquid helium facility online
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RHT (ASX) to my watchlist
(20min delay)
Last
6.4¢ 		Change
0.003(4.92%) 		Mkt cap ! $28.60M
Open High Low Value Volume
6.4¢ 6.4¢ 6.4¢ $2.187K 34.17K

Buyers (Bids)

No. Vol. Price($)
1 19354 6.1¢
 

Sellers (Offers)

Price($) Vol. No.
6.5¢ 10000 1
View Market Depth
Last trade - 10.28am 09/08/2024 (20 minute delay) ?
RHT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.